{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:53:14Z","timestamp":1761519194781},"reference-count":22,"publisher":"The Endocrine Society","issue":"9","license":[{"start":{"date-parts":[[2017,7,7]],"date-time":"2017-07-07T00:00:00Z","timestamp":1499385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9,1]]},"DOI":"10.1210\/js.2017-00156","type":"journal-article","created":{"date-parts":[[2017,7,7]],"date-time":"2017-07-07T14:09:08Z","timestamp":1499436548000},"page":"1124-1134","source":"Crossref","is-referenced-by-count":4,"title":["Somatic VHL Mutation in a Patient With MEN1-Associated Metastatic Pancreatic Neuroendocrine Tumor Responding to Sunitinib Treatment: A Case Report"],"prefix":"10.1210","volume":"1","author":[{"given":"Jasmine","family":"Shell","sequence":"first","affiliation":[{"name":"Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhaval","family":"Patel","sequence":"additional","affiliation":[{"name":"Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astin","family":"Powers","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Quezado","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Killian","sequence":"additional","affiliation":[{"name":"Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Meltzer","sequence":"additional","affiliation":[{"name":"Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Zhu","sequence":"additional","affiliation":[{"name":"Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apostolos","family":"Gaitanidis","sequence":"additional","affiliation":[{"name":"Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima","family":"Karzai","sequence":"additional","affiliation":[{"name":"Genitourinary Malignancies Branch, Medical Oncology Service, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Neychev","sequence":"additional","affiliation":[{"name":"Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patience","family":"Green","sequence":"additional","affiliation":[{"name":"Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Electron","family":"Kebebew","sequence":"additional","affiliation":[{"name":"Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892"},{"name":"Department of Surgery, The George Washington University School of Medicine and Health Sciences, Washington, DC 20052"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2017,7,7]]},"reference":[{"issue":"6021","key":"2019041122012435600_B1","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.1200609","article-title":"DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors","volume":"331","author":"Jiao","year":"2011","journal-title":"Science"},{"issue":"9","key":"2019041122012435600_B2","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019041122012435600_B3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1159\/000079616","article-title":"Hereditary pancreatic endocrine tumours","volume":"4","author":"Alexakis","year":"2004","journal-title":"Pancreatology"},{"issue":"12","key":"2019041122012435600_B4","first-page":"4568","article-title":"Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas","volume":"85","author":"Bender","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041122012435600_B5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5858\/arpa.2013-0520-RS","article-title":"Endocrine manifestations of von Hippel-Lindau disease","volume":"139","author":"Cassol","year":"2015","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"2019041122012435600_B6","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrclinonc.2016.37","article-title":"Evaluation and management of pancreatic lesions in patients with von Hippel-Lindau disease","volume":"13","author":"Keutgen","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"2019041122012435600_B7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/gcc.1180","article-title":"Role of disease-causing genes in sporadic pancreatic endocrine tumors: MEN1 and VHL","volume":"32","author":"Moore","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"2019041122012435600_B8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9440(10)65289-3","article-title":"Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms","volume":"154","author":"G\u00f6rtz","year":"1999","journal-title":"Am J Pathol"},{"issue":"5","key":"2019041122012435600_B9","doi-asserted-by":"crossref","first-page":"e008248","DOI":"10.1136\/bmjopen-2015-008248","article-title":"Mutation-targeted therapy with sunitinib or everolimus in patients with advanced low-grade or intermediate-grade neuroendocrine tumours of the gastrointestinal tract and pancreas with or without cytoreductive surgery: protocol for a phase II clinical trial","volume":"5","author":"Neychev","year":"2015","journal-title":"BMJ Open"},{"issue":"1","key":"2019041122012435600_B10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1200\/JCO.2009.24.2669","article-title":"Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial","volume":"28","author":"Yao","year":"2010","journal-title":"J Clin Oncol"},{"issue":"6","key":"2019041122012435600_B11","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJMoa1003825","article-title":"Sunitinib malate for the treatment of pancreatic neuroendocrine tumors","volume":"364","author":"Raymond","year":"2011","journal-title":"N Engl J Med"},{"issue":"7","key":"2019041122012435600_B12","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1507\/endocrj.K09E-126","article-title":"Unusual clinical and pathological presentation of a neuroendocrine tumor in a patient with multiple endocrine neoplasia type 1","volume":"56","author":"Sakurai","year":"2009","journal-title":"Endocr J"},{"issue":"2","key":"2019041122012435600_B13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ijc.11060","article-title":"Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas","volume":"105","author":"Dannenberg","year":"2003","journal-title":"Int J Cancer"},{"issue":"4","key":"2019041122012435600_B14","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1677\/ERC-08-0297","article-title":"VHL inactivation is an important pathway for the development of malignant sporadic pancreatic endocrine tumors","volume":"16","author":"Schmitt","year":"2009","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"2019041122012435600_B15","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.886","article-title":"Deletion at 3p25.3-p23 is frequently encountered in endocrine pancreatic tumours and is associated with metastatic progression","volume":"194","author":"Barghorn","year":"2001","journal-title":"J Pathol"},{"issue":"7","key":"2019041122012435600_B16","first-page":"1952","article-title":"High frequency loss of heterozygosity in von Hippel-Lindau (VHL)-associated and sporadic pancreatic islet cell tumors: evidence for a stepwise mechanism for malignant conversion in VHL tumorigenesis","volume":"62","author":"Lott","year":"2002","journal-title":"Cancer Res"},{"issue":"3","key":"2019041122012435600_B17","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1158\/1078-0432.CCR-1068-3","article-title":"Different molecular profiles characterize well-differentiated endocrine tumors and poorly differentiated endocrine carcinomas of the gastroenteropancreatic tract","volume":"10","author":"Furlan","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2019041122012435600_B18","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/(SICI)1098-2264(199911)26:3<258::AID-GCC11>3.0.CO;2-2","article-title":"Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors","volume":"26","author":"Hessman","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"issue":"16","key":"2019041122012435600_B19","first-page":"3706","article-title":"Localization of putative tumor suppressor loci by genome-wide allelotyping in human pancreatic endocrine tumors","volume":"58","author":"Chung","year":"1998","journal-title":"Cancer Res"},{"issue":"16","key":"2019041122012435600_B20","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1158\/1078-0432.CCR-10-2847","article-title":"Brivanib, a dual FGF\/VEGF inhibitor, is active both first and second line against mouse pancreatic neuroendocrine tumors developing adaptive\/evasive resistance to VEGF inhibition","volume":"17","author":"Allen","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2019041122012435600_B21","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1210\/jc.2008-1972","article-title":"Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors","volume":"94","author":"Jimenez","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019041122012435600_B22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.beem.2007.01.006","article-title":"Molecular targeted therapy for carcinoid and islet-cell carcinoma","volume":"21","author":"Yao","year":"2007","journal-title":"Best Pract Res Clin Endocrinol Metab"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jes\/article-pdf\/1\/9\/1124\/19546894\/js.2017-00156.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T09:24:50Z","timestamp":1555061090000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/1\/9\/1124\/3933365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,7]]},"references-count":22,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,7,7]]},"published-print":{"date-parts":[[2017,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/js.2017-00156","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,9,1]]},"published":{"date-parts":[[2017,7,7]]}}}